# Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood

> **NCT04285814** · — · COMPLETED · sponsor: **Columbia University** · enrollment: 33 (actual)

## Conditions studied

- Copy Number Abnormality
- Prenatal Diagnosis
- Genetic Disease

## Interventions

- **DIAGNOSTIC_TEST:** Whole Fetal Cell (WFC) Testing

## Key facts

- **NCT ID:** NCT04285814
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-07-20
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-01-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04285814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04285814, "Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04285814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*